Maximizing the Value of Drug Stockpiles for Pandemic Influenza
Open Access
- 1 October 2009
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 15 (10) , 1686-1687
- https://doi.org/10.3201/eid1510.090844
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Stockpiling Supplies for the Next Influenza PandemicEmerging Infectious Diseases, 2009
- Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label studyVaccine, 2006
- 1918 Influenza: the Mother of All PandemicsEmerging Infectious Diseases, 2006
- 1918 Influenza: the Mother of All PandemicsEmerging Infectious Diseases, 2006
- Too much, too little, or none at all: dealing with substandard and fake drugsThe Lancet, 2001
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999
- Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071Antimicrobial Agents and Chemotherapy, 1998
- Solid-State Stability of Aspirin in the Presence of Excipients: Kinetic Interpretation Modeling PredictionJournal of Pharmaceutical Sciences, 1982